Ibuprofen Lysine: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 April 2024

  • curprev 18:4718:47, 30 April 2024‎ Alara E. Dagsali talk contribs‎ 15,666 bytes +3‎ No edit summary
  • curprev 18:4618:46, 30 April 2024‎ Alara E. Dagsali talk contribs‎ 15,663 bytes +15,663‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=Ibuprofen lysine |aOrAn=a |indicationType=treatment |indication=Ibuprofen Lysine is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective. The clinical trial was conduc..."
Retrieved from "https://www.wikidoc.org/index.php/Ibuprofen_Lysine"